Abiopharma

🔍 Goldberg Chen (Executive)

Company: CoreWeave, Inc. (CRWV)

Report Date: 2026-05-05

Detailed Transactions and Holdings:

• Acquired 37,500 shares of Class A Common Stock (Direct)
  Date: 2026-05-05 | Code: M | equity_swap_involved: 0 | shares_owned_after: 81,567.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 19,222 shares of Class A Common Stock at $125.0 per share (Direct)
  Date: 2026-05-05 | Code: S | equity_swap_involved: 0 | shares_owned_after: 62,345.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 37,500 shares of Restricted Stock Units (Derivative)
  Date: 2026-05-05 | Code: M | equity_swap_involved: 0 | shares_owned_after: 337,500.00 | transaction_form_type: 4 | Footnotes: F1, F1, F3, F4

Footnotes:

• F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement.
• F2: The reported transaction represents shares of Class A Common Stock of the Issuer sold to satisfy the reporting person's tax withholding obligations, which were incurred in connection with the vesting and settlement of restricted stock units.
• F3: The award vested as to 1/4 of the total award on August 5, 2025, and vests as to 1/16 of the total award thereafter on the fifth calendar day of November, February, May, and August, subject to the reporting person's continued service to the Issuer on each vesting date.
• F4: These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date.